BDBM72386 (E)-3-(4-methoxyphenyl)-N-(3-phenylpropyl)-2-propenamide::(E)-3-(4-methoxyphenyl)-N-(3-phenylpropyl)acrylamide::(E)-3-(4-methoxyphenyl)-N-(3-phenylpropyl)prop-2-enamide::MLS000672938::SMR000272157::cid_2165464

SMILES O=C1c2cc(F)c(F)cc2N2CN1c1ccc(=O)[nH]c1NCCCc1c2ccc(F)c1F

InChI Key InChIKey=HYNBHAVCKOHIDZ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72386   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72386BDBM72386(2,3,8,9-Tetrafluoro-10,11,12,13-tetrahydro-19H-5,1...)
Affinity DataIC50: 25.1nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent